These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38112831)

  • 41. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer.
    Tsai WS; You JF; Hung HY; Hsieh PS; Hsieh B; Lenz HJ; Idos G; Friedland S; Yi-Jiun Pan J; Shao HJ; Wu JC; Lai JM; Chang SE; Mei R; Watson D; Javey M; Nimgaonkar A
    Clin Transl Gastroenterol; 2019 Oct; 10(10):e00088. PubMed ID: 31663904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
    Lu G; Lu Z; Li C; Huang X; Luo Q
    Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis.
    Tan Y; Wu H
    Curr Probl Cancer; 2018; 42(1):95-106. PubMed ID: 29277243
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
    Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
    Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic value of magnetic resonance and computed tomography colonography for the diagnosis of colorectal cancer: A systematic review and meta-analysis.
    Gao Y; Wang J; Lv H; Xue Y; Jia R; Liu G; Bai W; Wu Y; Zhang L; Yang J
    Medicine (Baltimore); 2019 Sep; 98(39):e17187. PubMed ID: 31574825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment.
    Cui F; Qu D; Sun R; Tao H; Si J; Xu Y
    Dis Markers; 2019; 2019():7152183. PubMed ID: 31636738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A preliminary study of the clinical significance of folate receptor-positive circulating tumor cell in the management of hepatobiliary-pancreatic cancers.
    He YG; Zheng L; Gao MF; Tang YC; Li YM; Yu KH; Li J; Huang XB
    Transl Cancer Res; 2020 Nov; 9(11):6700-6709. PubMed ID: 35117280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mean platelet volume/platelet count ratio in combination with tumor markers in colorectal cancer: a retrospective clinical study.
    Zhang H; Lin F; Wang Z
    BMC Cancer; 2023 Feb; 23(1):124. PubMed ID: 36750793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating tumor cell levels are elevated in colorectal cancer patients with high tumor burden in the liver.
    Kaifi JT; Kunkel M; Dicker DT; Joude J; Allen JE; Das A; Zhu J; Yang Z; Sarwani NE; Li G; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2015; 16(5):690-8. PubMed ID: 25785486
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Circulating tumor cells are associated with diffuse spread in stage IV colorectal cancer patients.
    Kaifi JT; Kunkel M; Zhu J; Dicker DT; Gusani N; Yang Z; Sarwani NE; Li G; Kimchi ET; Staveley-O'Carroll KF; El-Deiry WS
    Cancer Biol Ther; 2013 Dec; 14(12):1174-81. PubMed ID: 24153154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study.
    Dizdar L; Fluegen G; van Dalum G; Honisch E; Neves RP; Niederacher D; Neubauer H; Fehm T; Rehders A; Krieg A; Knoefel WT; Stoecklein NH
    Mol Oncol; 2019 Jul; 13(7):1548-1558. PubMed ID: 31116510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
    Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
    Front Oncol; 2022; 12():769203. PubMed ID: 35425708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
    Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
    J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
    [No Abstract]   [Full Text] [Related]  

  • 54. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
    Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
    J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: a pilot study.
    Garrigós N; Gallego J; Guillén-Ponce C; Guaraz P; García-Bautista M; Castillejo A; Gómez-Martínez A; Carrato A; Rodríguez-Lescure A; Soto JL
    Clin Transl Oncol; 2010 Feb; 12(2):142-7. PubMed ID: 20156783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating fibrinogen to pre-albumin ratio is a promising biomarker for diagnosis of colorectal cancer.
    Sun F; Tan YA; Gao QF; Li SQ; Zhang J; Chen QG; Jiang YH; Zhang L; Ying HQ; Wang XZ
    J Clin Lab Anal; 2019 Jan; 33(1):e22635. PubMed ID: 30047185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal change of circulating tumor cell level and its relationship with immune checkpoint inhibitor-based treatment benefits in unresectable, metastatic colorectal cancer patients.
    Fan H; Bai L; Bai K
    Scand J Clin Lab Invest; 2023 Jul; 83(4):227-233. PubMed ID: 37247200
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Prospective Long-Term Follow-Up Study: The Application of Circulating Tumor Cells Analysis to Guide Adjuvant Therapy in Stage II Colorectal Cancer.
    Yu J; Bai Y; Jin L; Zhang Z; Yang Y
    Ann Surg Oncol; 2023 Dec; 30(13):8495-8500. PubMed ID: 37598121
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between circulating tumor cells and tumor response in colorectal cancer patients treated with chemotherapy: a meta-analysis.
    Huang X; Gao P; Song Y; Sun J; Chen X; Zhao J; Liu J; Xu H; Wang Z
    BMC Cancer; 2014 Dec; 14():976. PubMed ID: 25519477
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.
    Luo S; Ou Y; Zheng T; Jiang H; Wu Y; Zhao J; Zhang Z
    J Oncol; 2021; 2021():1517488. PubMed ID: 34976053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.